Medigus Ltd. Series C Warrant
MDGSW
MDGSW was delisted on the 19th of July, 2023.
4 hedge funds and large institutions have $2.36M invested in Medigus Ltd. Series C Warrant in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
142% more capital invested
Capital invested by funds: $973K → $2.36M (+$1.39M)
100% more funds holding
Funds holding: 2 → 4 (+2)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$874K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$14.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$153K |
MDGSW Hedge Fund Activity: Q4 2018 in Review
4 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Medigus Ltd. Series C Warrant (MDGSW) for Q4 2018, worth a combined $2.36M — up 142% from $973K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new MDGSW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $874K. The largest seller was Sabby Management, cutting an estimated $153K.
- 4 institutional investors held Medigus Ltd. Series C Warrant (MDGSW) as of Q4 2018, up from 2 in Q3 2018.
- Funds reported $2.36M of Medigus Ltd. Series C Warrant stock for Q4 2018, up 142% quarter-over-quarter.
- 2 funds opened new Medigus Ltd. Series C Warrant positions in Q4 2018 and 0 closed out, a net change of +2 holders.
- The largest Medigus Ltd. Series C Warrant buyer in Q4 2018 was Armistice Capital, an estimated $874K added.
- The largest Medigus Ltd. Series C Warrant seller in Q4 2018 was Sabby Management, an estimated $153K sold.
Based on aggregated 13F filings for Q4 2018.